Sign up
Log in
title
Osteoporosis Meds May Cut Breast Cancer Risk: Study

Women who took a commonly used class of osteoporosis drugs called bisphosphonates had significantly fewer invasive breast cancers than women not using the bone-strengthening pills, according to a new analysis of data from the Women's Health Initiative (WHI). The analysis from a segment of the more than 150,000 generally healthy post-menopausal women in the WHI study found that those taking Merck & Co's Fosamax, or other bisphosphonates, had 32 percent fewer cases of invasive breast cancer than women who did not use the osteoporosis medicines, researchers found.

Source: http://www.reuters.com/article/idUSTRE5B942H20091210

Created by: mellie | Created at: 07:09 PM - March 14, 2010
Ad Ranking: 3.3


Add Comment